Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Annals of the Rheumatic Diseases
|
November 27, 2004
Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus
M N Lub-de Hooge, E G E de Vries, S de Jong, et al.
Clinical Pharmacokinetics
|
March 31, 2023
Pharmacokinetics and Pharmacodynamics of Ruxolitinib: A Review
T Y J Appeldoorn, T H Oude Munnink, L M Morsink, et al.
PDA Journal of Pharmaceutical Science and Technology
|
April 20, 2011
Intravenous administration of recombinant human IL-10 suppresses the development of anti-thy 1-induced glomerulosclerosis in rats
H Rachmawati, L Beljaars, C Reker-Smit, et al.
Clinical Pharmacokinetics
|
March 20, 2023
The Pharmacokinetics and Target Attainment of Antimicrobial Drugs Throughout Pregnancy: Part III Non-penicillin and Non-cephalosporin Drugs
F Groen, J R Prins, M N Lub-de Hooge, et al.
Clinical Pharmacokinetics
|
January 20, 2023
Pharmacokinetics and Target Attainment of Antimicrobial Drugs Throughout Pregnancy: Part I-Penicillins
M R Hesse, J R Prins, M N Lub-de Hooge, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
December 20, 2005
Molecular imaging: what can be used today
P L Jager, M A de Korte, M N Lub-de Hooge, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 31, 2018
<sup>89</sup>Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up
Frederike Bensch, A H Brouwers, M N Lub-de Hooge, et al.
Pharmacology & Therapeutics
|
December 3, 2014
Targeting breast cancer through its microenvironment: current status of preclinical and clinical research in finding relevant targets
H H Nienhuis, S B M Gaykema, H Timmer-Bosscha, et al.
Breast (Edinburgh, Scotland)
|
November 17, 2009
Molecular imaging of breast cancer
T H Oude Munnink, W B Nagengast, A H Brouwers, et al.
British Journal of Pharmacology
|
October 22, 2011
Development of a radioiodinated apoptosis-inducing ligand, rhTRAIL, and a radiolabelled agonist TRAIL receptor antibody for clinical imaging studies
E W Duiker, E C F Dijkers, H Lambers Heerspink, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Annals of the Rheumatic Diseases
|
November 27, 2004
Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus
M N Lub-de Hooge, E G E de Vries, S de Jong, et al.
Clinical Pharmacokinetics
|
March 31, 2023
Pharmacokinetics and Pharmacodynamics of Ruxolitinib: A Review
T Y J Appeldoorn, T H Oude Munnink, L M Morsink, et al.
PDA Journal of Pharmaceutical Science and Technology
|
April 20, 2011
Intravenous administration of recombinant human IL-10 suppresses the development of anti-thy 1-induced glomerulosclerosis in rats
H Rachmawati, L Beljaars, C Reker-Smit, et al.
Clinical Pharmacokinetics
|
March 20, 2023
The Pharmacokinetics and Target Attainment of Antimicrobial Drugs Throughout Pregnancy: Part III Non-penicillin and Non-cephalosporin Drugs
F Groen, J R Prins, M N Lub-de Hooge, et al.
Clinical Pharmacokinetics
|
January 20, 2023
Pharmacokinetics and Target Attainment of Antimicrobial Drugs Throughout Pregnancy: Part I-Penicillins
M R Hesse, J R Prins, M N Lub-de Hooge, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
December 20, 2005
Molecular imaging: what can be used today
P L Jager, M A de Korte, M N Lub-de Hooge, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 31, 2018
<sup>89</sup>Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up
Frederike Bensch, A H Brouwers, M N Lub-de Hooge, et al.
Pharmacology & Therapeutics
|
December 3, 2014
Targeting breast cancer through its microenvironment: current status of preclinical and clinical research in finding relevant targets
H H Nienhuis, S B M Gaykema, H Timmer-Bosscha, et al.
Breast (Edinburgh, Scotland)
|
November 17, 2009
Molecular imaging of breast cancer
T H Oude Munnink, W B Nagengast, A H Brouwers, et al.
British Journal of Pharmacology
|
October 22, 2011
Development of a radioiodinated apoptosis-inducing ligand, rhTRAIL, and a radiolabelled agonist TRAIL receptor antibody for clinical imaging studies
E W Duiker, E C F Dijkers, H Lambers Heerspink, et al.
Page
of 2